Tim has over 6 years’ of healthcare investment banking experience, having joined CG Results in 2016 as an Associate. He has worked with early stage and founder-led companies, private equity and corporate clients on a variety of transactions and projects including divestments, acquisitions, fundraising, investments and strategic reviews. He has advised investors, pharma, biotech and healthtech clients as well as outsourced providers of manufacturing, research, and commercial services to the life science industry.
Prior to CG Results Tim spent 7 years in the biopharma industry, the first 4 of which as a development scientist in a CDMO before moving into a corporate role at an early-stage biotech company. Tim holds a Masters degree in Biochemical Engineering and has passed Level II of the CFA program.
Outside of work, Tim enjoys surfing, snowboarding and bouldering.
Pharma Commercialisation Services Update – February 2023
Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]
MedTech Services – Drivers of growth and consolidation
Welcome to our MedTech Services Report. This sets out our views on the tailwinds driving growth and increased outsourcing, an overview of the MedTech CDMO and CRO market as well as the key drivers of consolidation in the sector. We hope that you enjoy this report and look forward to discussing the data and underlying […]
Pharma Commercialisation Services Update – September 2022
Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]
Pharma Commercialisation Services Update – February 2022
We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector. For some time, CG Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, […]
CRO sector M&A drivers and market trends
Contract Research Organisations (CROs) typically provide discovery and development services to the pharmaceutical, biotechnology and medical devices industries (frequently referred to as sponsors), but can also support foundations, research institutions and universities. CROs co-ordinate and execute activities throughout the R&D pathway, by organising and conducting clinical trials to test the new molecule in humans. As […]
Meet The Team
Business and People Support Manager